E-LIB Suche - Ergebnisse für: Samperiz, Gloria

1

Long-term evolution in liver disease markers and immune and..:

Tarancon-Diez, Laura ; Carrasco, Itzíar ; Jiménez de Ory, Santiago...
Biomedicine & Pharmacotherapy. 162 (2023) - p. 114587 , 2023

Link: https://doi.org/10.1016/..

2

COVID‐19 in hospitalized HIV‐positive and HIV‐negative pati..:

Díez, Cristina ; Del Romero‐Raposo, Jorge ; Mican, Rafael...
HIV Medicine. 22 (2021) 9 - p. 867-876 , 2021

Link: https://doi.org/10.1111/..

3

Differences in epidemiology and mortality between men and w..:

Muñoz Hornero, Constanza ; Muriel, Alfonso ; Montero, Marta...
Enfermedades infecciosas y microbiologia clinica (English ed.). 39 (2021) 8 - p. 372-382 , 2021

Link: https://doi.org/10.1016/..

4

Late HIV diagnosis among immigrants in Spain vs. native-bor..:

Gogishvili, Megi ; Huang, Terry T -K ; Costa, Sergio A...
European Journal of Public Health. 31 (2021) 6 - p. 1123-1128 , 2021

Link: https://doi.org/10.1093/..

5

Increased rate of FEV1 decline in HIV patients despite effe..:

Samperiz, Gloria ; Fanjul, Francisco ; Valera, Jose Luis...
PLOS ONE. 14 (2019) 10 - p. e0224510 , 2019

Link: https://doi.org/10.1371/..

6

Effectiveness and safety of dual therapy with rilpivirine a..:

on behalf of the RIDAR Study Group ; Pasquau, Juan ; de Jesus, Samantha E....
BMC Infectious Diseases. 19 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

7

Interatrial blocks prevalence and risk factors for human im..:

Fanjul, Francisco ; Campins, Antoni ; Asensio, Javier...
PLOS ONE. 14 (2019) 10 - p. e0223777 , 2019

Link: https://doi.org/10.1371/..

8

Raltegravir plus abacavir/lamivudine in virologically suppr..:

Troya, Jesús ; Montejano, Rocio ; Ryan, Pablo...
PLOS ONE. 13 (2018) 6 - p. e0198768 , 2018

Link: https://doi.org/10.1371/..

9

Pharmacogenetics of Efficacy and Safety of HCV Treatment in..:

Vidal, Francesc ; López-Dupla, Miguel ; Laguno, Montserrat...
PLoS ONE. 7 (2012) 11 - p. e47725 , 2012

Link: https://doi.org/10.1371/..

10

Effectiveness and tolerability of dolutegravir and abacavir..:

Suárez‐García, Inés ; Alejos, Belén ; Ruiz‐Algueró, Marta...
Journal of the International AIDS Society. 24 (2021) 7 - p. , 2021

Link: https://doi.org/10.1002/..

11

Physicians' opinions on generic antiretroviral drugs and si..:

Suárez-García, Inés ; Ruiz-Algueró, Marta ; García Yubero, Cristina...
Journal of Antimicrobial Chemotherapy. , 2019

Link: https://doi.org/10.1093/..

12

COVID-19 in hospitalized HIV-positive and HIV-negative pati..:

Díez, Cristina ; Del Romero-Raposo, Jorge ; Mican, Rafael...
https://doi.org/10.1111/hiv.13145. , 2021

Link: https://hdl.handle.net/2..

13

Effectiveness and safety of dual therapy with rilpivirine a..:

Pasquau-Liaño, Juan ; Jesus, Samantha E. de ; Arazo, Piedad...
Publisher's version. , 2019

Link: http://hdl.handle.net/10..

14

Effectiveness and safety of dual therapy with rilpivirine a..:

Pasquau, Juan ; de Jesus, Samantha E ; Arazo, Piedad...
http://hdl.handle.net/10668/13642. , 2019

Link: http://hdl.handle.net/10..

15

Increased rate of FEV1 decline in HIV patients despite effe..:

Sampériz, Gloria ; Fanjul, Francisco ; Valera, José Luis...
Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0224510. , 2019

Link: http://hdl.handle.net/24..